1 Kim, SG, "p53-independent induction of Fas and apoptosis in leukemic cells by an adenosine derivative, Cl-IB-MECA" 6 : 871-880, 2002
2 Levine AJ, "p53, the cellular gatekeeper for growth and division" 88 : 323-331, 1997
3 Tewari M, "Yama/CPP32 beta, a mammalian homolog for CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase" 81 : 801-809, 1995
4 Cheng SL, "Toxicogenomics of A375 human malignant melanoma cells treated with arbutin" 14 : 87-105, 2007
5 Henry H, "Regulation of the mitochondrial checkpoint in p53-mediated apoptosis confers resistance to cell death" 21 : 748-760, 2002
6 Hansen MB, "Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill" 11 : 203-210, 1989
7 Simmons TL, "Marine natural products as anticancer drugs" 4 : 333-342, 2005
8 Yuru M, "Lysophosphatidic acid inhibits anti-Fas-mediated apoptosis enhanced by actin depolymerization in epithelial ovarian cancer" 579 : 1311-1319, 2005
9 Suzuki M, "Halogenated and nonhalogenated aromatic sesquiterpenes from the red algae Laurencia okamurai Yamada" 52 : 3352-3354, 1979
10 Lin D, "Growth arrest induced by wild-type p53 protein blocks cells prior to or near the restriction point in late G1 phase" 89 : 9210-9214, 1992
1 Kim, SG, "p53-independent induction of Fas and apoptosis in leukemic cells by an adenosine derivative, Cl-IB-MECA" 6 : 871-880, 2002
2 Levine AJ, "p53, the cellular gatekeeper for growth and division" 88 : 323-331, 1997
3 Tewari M, "Yama/CPP32 beta, a mammalian homolog for CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase" 81 : 801-809, 1995
4 Cheng SL, "Toxicogenomics of A375 human malignant melanoma cells treated with arbutin" 14 : 87-105, 2007
5 Henry H, "Regulation of the mitochondrial checkpoint in p53-mediated apoptosis confers resistance to cell death" 21 : 748-760, 2002
6 Hansen MB, "Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill" 11 : 203-210, 1989
7 Simmons TL, "Marine natural products as anticancer drugs" 4 : 333-342, 2005
8 Yuru M, "Lysophosphatidic acid inhibits anti-Fas-mediated apoptosis enhanced by actin depolymerization in epithelial ovarian cancer" 579 : 1311-1319, 2005
9 Suzuki M, "Halogenated and nonhalogenated aromatic sesquiterpenes from the red algae Laurencia okamurai Yamada" 52 : 3352-3354, 1979
10 Lin D, "Growth arrest induced by wild-type p53 protein blocks cells prior to or near the restriction point in late G1 phase" 89 : 9210-9214, 1992
11 Virgili G, "EUROCARE Working Group: Incidence of uveal melanoma in Europe" 114 : 2309-2315, 2007
12 Lin MT, "Differential expression of tissue- specific promoters by gene gun" 14 : 34-39, 2001
13 Sakahira H, "Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis" 39 : 96-99, 1998
14 Li G, "Chemotherapy-induced apoptosis in melanoma cells is p53 dependent" 8 : 17-23, 1998
15 Ryan KM, "Characterization of structural p53 mutants which show selective defects in apoptosis, but not cell cycle arrest" 18 : 3692-3698, 1998
16 Wu GS, "Caspase-9 is required for p53-independent apoptosis and chemosensitivity in a human ovarian cancer cell line" 2 : 1-8, 2002
17 Janicke RU, "Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis" 27 : 9357-9360, 1998
18 Carter GT, "Brominated indoles from Laurencia brongniartii" 19 : 4479-4482, 1978
19 Manson MM, "Blocking and suppressing mechanism of chemoprevention by dietary constituents" 113 : 499-505, 2000
20 Velculescu VE, "Biological and clinical importance of the p53 tumor suppressor gene" 42 : 858-868, 1996
21 Basma H, "BCL-2 antisense and cisplatin combination treatment of MCF-7 breast cancer cells with or without functional p53" 12 : 999-1011, 2005
22 Yu HS, "Arsenic carcinogenesis in the skin" 13 : 657-666, 2006
23 Lin HH, "Apoptotic cleavage of NuMA at the C-terminal end is related to nuclear disruption and death amplification" 14 : 681-694, 2007
24 Guchelaar HJ, "Apoptosis: molecular mechanisms and implications for cancer chemotherapy" 19 : 119-125, 1997
25 Sims JJ, "Antimicrobial agents from marine algae" 7 : 320-321, 1975
26 Vairappan CS, "Antibacterial halogenated metabolites from the Malaysian Laurencia species" 58 : 291-297, 2001
27 Cirielli C, "Adenovirus-mediated gene transfer of wild-type p53 results in melanoma cell apoptosis in vitro and in vivo" 63 : 673-679, 1995